
|Articles|November 1, 2003
- Pharmaceutical Executive-11-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
The Ten Billion Dollar Moleculeover 22 years ago
The Path to Smart R&DAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




